Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

9p Rearrangements in ALL

Identity

 
  del(9p) G- banding - Courtesy Jean-Luc Lai and Alain Vanderhaegen

Clinics and Pathology

Disease acute lymphocycic leukemia (ALL)
Phenotype / cell stem origin lack of specificity for a particular immunophenotype
Epidemiology approximately 10% of childhood ALL, similar in adult ALL
Prognosis recent data indicate that an abnormal 9p is an adverse risk factor for B-lineage, but not T-lineage pediatric patients; this is more pronounced in standard-risk patients (age 1 - 9 years with WBC count <50 X 109/l); a dic(9;12)(p11-13;p11-12) has been reported to have a very low relapse rate

Cytogenetics

Cytogenetics Morphological various aberrations result in an abnormal 9p; these include monosomy 9, del(9p), add(9p), der(9)t(V;9)(V;p), dic(V;9)(V;p), i(9q) and balanced translocations with 9p breakpoints; dicentric chromosomes in ALL nearly always involve a chromosome 9; an abnormal 9p usually occurs as part of a more complex karyotype; it occurs as a sole aberration in less than 10% of cases with an abnormal 9p
Additional anomalies additional anomalies are frequent; an abnormal 12p is particularly frequent (16% of cases), and a deletion of 6q is also frequent (11% of cases)

Genes involved and Proteins

Note the different types of 9p aberrations may have different molecular consequences; when a deletion of 9p occurs, the genes involved colud be MTS1/CDK4I/p16INK4A(CDKN2) and MTS2/p15INK4B(CDKN2B); these are believed to be tumor suppressor genes, and loss of heterozygosity occurs more frequently than cytogenetic deletions of 9p; however, mutation of the remaining allele is infrequent, and methylation changes may cause inactivation of the remaining allele

Bibliography

Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9.
Chilcote RR, Brown E, Rowley JD
The New England journal of medicine. 1985 ; 313 (5) : 286-291.
PMID 3925340
 
Lack of association between abnormalities of the chromosome 9 short arm and either lymphomatous features or T cell phenotype in childhood acute lymphocytic leukemia.
Carroll AJ, Castleberry RP, Crist WM
Blood. 1987 ; 69 (3) : 735-738.
PMID 3493041
 
Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: report from a dic(9;12) study group.
Behrendt H, Charrin C, Gibbons B, Harrison CJ, Hawkins JM, Heerema NA, Horschler-Btel B, Huret JL, La JL, Lampert F
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1995 ; 9 (1) : 102-106.
PMID 7845002
 
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
Drexler HG
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 1998 ; 12 (6) : 845-859.
PMID 9639410
 
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
Heerema NA, Sather HN, Sensel MG, Liu-Mares W, Lange BJ, Bostrom BC, Nachman JB, Steinherz PG, Hutchinson R, Gaynon PS, Arthur DC, Uckun FM
Blood. 1999 ; 94 (5) : 1537-1544.
PMID 10477677
 

Contributor(s)

Written08-1999Nyla A Heerema

Citation

This paper should be referenced as such :
Heerema NA . 9p Rearrangements in ALL. Atlas Genet Cytogenet Oncol Haematol. August 1999 .
URL : http://AtlasGeneticsOncology.org/Genes/9prearrALLID1156.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Jul 14 16:31:50 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.